Get started
Author

Özlem Kral

Observed names: Kral, Özlem, Özlem KRAL
ORCID: 0000-0003-1420-8462
Observed ORCID: 0000-0003-1420-8462
OpenAlex ID: A5014386010
Development of Dermal Lidocaine Nanosuspension Formulation by the Wet Milling Method Using Experimental Design: In Vitro/In Vivo Evaluation
2024 · Özlem Kral, Sibel Ilbasmis-Tamer, et al. · ACS Omega · 20
Development of nanosuspension-based thermosensitive gel formulation for radiodermatitis treatment: In vitro-in vivo characterization and investigation of neutron-gamma absorption properties
2025 · Özlem Kral, Sibel Ilbasmis-Tamer, et al. · Journal of Drug Delivery Science and Technology · 4
Soaking-Loaded Diclofenac Sodium Buccal Films Fabricated by FDM 3D Printing
2026 · Özlem Kral, Aysel Yılmaz · Journal of Pharmaceutical Innovation · 3
PDF
Development and Characterization of a Topical Herniarin Ointment from Tarragon
2025 · Özlem Kral, Adalet Eralmaç, et al. · ChemistrySelect · 3
Formulation and Cytotoxicity Assessment of Methylprednisolone Aceponate Microemulsions for Topical Delivery
2025 · Özlem Kral, Gülser Hennep, et al. · Journal of Pharmaceutical Innovation · 1
Radiodermatitis Treatment: Traditional Review
2023 · Özlem KRAL, Sibel İLBASMIŞ TAMER, et al. · Turkiye Klinikleri Journal of Dermatology · 1
PDF
Development of Ornidazole-Loaded Emulgel: Formulation Optimization and In Vitro Characterization
2026 · Özlem Kral, İrem Özel · Fabad Journal of Pharmaceutical Sciences
PDF
Ornidazol Yüklü Emüljel Geliştirilmesi: Formülasyon Optimizasyonu ve İn Vitro Karakterizasyon
2026 · Kral, Özlem, Özel, İrem · DergiPark (Istanbul University)
Works count: 8
Citation count: 32
H-index: 3
I10-index: 1
Year
Topic
Type